SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-052672
Filing Date
2021-04-21
Accepted
2021-04-20 18:33:22
Documents
71
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F tm2038025d1_20f.htm 20-F 3057057
2 EXHIBIT 2.2 tm2038025d1_ex2-2.htm EX-2.2 250546
3 EXHIBIT 21.1 tm2038025d1_ex21-1.htm EX-21.1 5280
4 EXHIBIT 23.1 tm2038025d1_ex23-1.htm EX-23.1 2693
5 EXHIBIT 31.1 tm2038025d1_ex31-1.htm EX-31.1 14761
6 EXHIBIT 31.2 tm2038025d1_ex31-2.htm EX-31.2 14972
7 EXHIBIT 32.1 tm2038025d1_ex32-1.htm EX-32.1 7322
8 EXHIBIT 32.2 tm2038025d1_ex32-2.htm EX-32.2 7319
  Complete submission text file 0001104659-21-052672.txt   31155785

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT aktx-20201231.xml EX-101.INS 13007445
10 XBRL TAXONOMY EXTENSION SCHEMA aktx-20201231.xsd EX-101.SCH 48776
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aktx-20201231_cal.xml EX-101.CAL 43848
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aktx-20201231_def.xml EX-101.DEF 231321
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE aktx-20201231_lab.xml EX-101.LAB 383940
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aktx-20201231_pre.xml EX-101.PRE 409893
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 20-F | Act: 34 | File No.: 001-36288 | Film No.: 21839039
SIC: 2834 Pharmaceutical Preparations